MAPT and Alzheimer disease: To investigate whether the treatment of 3×Tg-AD mice with young plasma for 2 months can influence tau pathology, we immunostained the mouse brain sections with AT8 antibody to tau pSer 202/pThr 205 and counted the number of neurons with positive AT8 staining in CA1 of the hippocampus.